Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Dexcom

Strong Tech Earnings Boost Stocks

The S&P 500 Index ($SPX ) (SPY ) Friday closed up +1.02%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.40%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.65%. US stock indexes rallied Friday, with the S&P 500 posting a 1-1/2 week high...

Stocks Climb on Impressive Tech Earnings and Strength in AI Chip Makers

Stocks Climb on Impressive Tech Earnings and Strength in AI Chip Makers

The S&P 500 Index ($SPX ) (SPY ) this morning is up +1.04%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.35%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.55%. US stock indexes this morning are moderately higher, with the S&P 500 climbing...

Stocks Rally on Blockbuster Earnings from Alphabet and Microsoft

Stocks Rally on Blockbuster Earnings from Alphabet and Microsoft

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.55%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.31%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.05%. US stock indexes this morning are moderately higher as blockbuster earnings results from...

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Deprived families unable to make most of NHS diabetes devices, say charities

Many people not benefiting fully from continuous glucose monitors because they cannot afford smartphones

The Guardian - UK

Stocks Slip on Higher Bond Yields and U.S. Shutdown Concerns

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.31%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.35%. Stocks this morning are mostly lower. Higher bond yields...

3 Standout Growth Stocks to Own for 2024

As the Fed continues to pump the brakes on rate hikes, here are three top-rated stocks expected to report strong earnings and revenue growth going forward.

Stocks Slide as Bond Yields Climb on Strong U.S. Economic Reports

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.28%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.06%. Stocks are sliding, with the Nasdaq 100 falling to...

inkl

Read news from The Economist, FT, and more,
with one subscription

Stocks Mixed as Bond Yields Climb on Strong U.S. Economic Reports

Stocks Mixed as Bond Yields Climb on Strong U.S. Economic Reports

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.27%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.04%. Stocks this morning are mixed, with the Nasdaq 100...

Stocks Drop as Bond Yields Climb on Strong U.S. Economic Reports

Stocks Drop as Bond Yields Climb on Strong U.S. Economic Reports

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.28%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.22%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.61%. Stocks this morning are moderately lower, with the Nasdaq...

Company's new wearable device will help diabetics eat right, lose weight

SAN DIEGO — San Diego's Dexcom, a maker of continuous glucose monitors, laid out plans for a new wearable device coming in 2024 for people with Type 2 diabetes who don't need insulin — a move that could help bring wearable health monitors closer to the mainstream.

Tribune News Service

Best Constant Glucose Monitor for Apple devices

Best Constant Glucose Monitor for Apple devices

What gets measured gets managed, and constant glucose monitors make managing diabetes far simpler.

This Is What Whales Are Betting On DexCom

This Is What Whales Are Betting On DexCom

Someone with a lot of money to spend has taken a bullish stance on DexCom (NASDAQ:DXCM). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Diabetes patients can now get ‘life-changing’ blood sugar gadget on the NHS

Diabetes patients can now get ‘life-changing’ blood sugar gadget on the NHS

Cutting edge technology could be beginning of the end for people needing to draw blood several times a day to test their levels

Benzinga's Top Ratings Upgrades, Downgrades For July 15, 2022

Benzinga's Top Ratings Upgrades, Downgrades For July 15, 2022

Get all your
news in one place.

100's of premium titles.
One news app.

The UK’s First Diabetic Giant Anteater Has Been Fitted With A Glucose Monitor

The first diabetic giant anteater in the United Kingdom has been fitted with a monitor to check its blood glucose levels – which is normally used on humans.

Here's How Much You Would Have Made Owning DexCom Stock In The Last 15 Years

DexCom (NASDAQ:DXCM) has outperformed the market over the past 15 years by 20.9% on an annualized basis producing an average annual return of 27.35%. Currently, DexCom has a market capitalization of $30.77 billion.

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $16,000 Today

DexCom (NASDAQ:DXCM) has outperformed the market over the past 5 years by 64.52% on an annualized basis producing an average annual return of 74.42%. Currently, DexCom has a market capitalization of $115.32 billion.

Here's How Much You Would Have Made Owning DexCom Stock In The Last 15 Years

DexCom (NASDAQ:DXCM) has outperformed the market over the past 15 years by 22.06% on an annualized basis producing an average annual return of 28.95%. Currently, DexCom has a market capitalization of $29.24 billion.

Get all your
news in one place.

100's of premium titles.
One news app.

What Are Whales Doing With DexCom

A whale with a lot of money to spend has taken a noticeably bearish stance on DexCom. Looking at options history for DexCom (NASDAQ:DXCM) we detected 25 strange trades.

Dexcom In Talks To Acquire Insulet, Create a Giant In Diabetes Devices: Bloomberg

Dexcom Inc (NYSE:DXCM) is reportedly in talks to acquire medical-device company Insulet Corporation (NASDAQ: PODD) to create a giant in diabetes devices, according to people with knowledge of the matter. According to Bloomberg, talks between the companies are ongoing, and an agreement could be reached in the coming weeks. Discussions could still be delayed or fall…

DexCom Earnings Perspective: Return On Invested Capital

Pulled from Benzinga Pro data, DexCom (NASDAQ:DXCM) posted Q1 earnings of $97.30 million, an increase from Q4 of 601.55%. Sales dropped to $628.80 million, a 9.94% decrease between quarters.

If You Invested $1000 In DexCom 10 Years Ago, Here's How Much You Would Have Today

DexCom (NASDAQ:DXCM) has outperformed the market over the past 10 years by 32.66% on an annualized basis producing an average annual return of 44.4%. Currently, DexCom has a market capitalization of $39.95 billion.

Read Here Why Did This Analyst Cut DexCom's Price Target

Recap: DexCom Q1 Earnings

DexCom (NASDAQ:DXCM) reported its Q1 earnings results on Thursday, April 28, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings DexCom missed estimated earnings by 38.46%, reporting an EPS of $0.32 versus an estimate of $0.52.

DexCom's Earnings: A Preview

DexCom (NASDAQ:DXCM) is set to give its latest quarterly earnings report on Thursday, 2022-04-28. Here's what investors need to know before the announcement. Analysts estimate that DexCom will report an earnings per share (EPS) of $0.52.

1 2 3 4

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

Intel Corporation

Delta Air Lines

University of Michigan

Dow Jones Industrials

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

359,338 stories

135,749 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play